The impact of cardiovascular disease on people with diabetes: The potential for prevention

Lancet

Volumn 350, Issue SUPPL.1, 1997, Pages 29-32

  Eastman, Richard C ^a   Keen, Harry ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030787533     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90026-x     Document Type: Article

References (29)

1. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 429-48.
2. Palumbo P, Melton LJ III. Peripheral vascular disease and diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 401-08.
3. Kuller L. Stroke and diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 449-56.
4. Fuller JH, Stevens LK, Wang SL. International variations in cardiovascular mortality associated with diabetes mellitus: the WHO Multinational Study of Vascular Disease in Diabetes. Ann Med 1996; 28: 319-22.
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
6. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987; 294: 1651-54.
7. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 1995; 12: 149-55.
8. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-41.
9. Mattock MB, Keen H, Barnes DJ, et al. Microalbuminuria: a risk factor for coronary heart disease in non-insulin dependent diabetic men. In:. Cardiovascular Disease Prevention III.Teddington, UK: Hampton Medical Conferences, 1997: 30 (abstr).
10. Marre M, Fabbri P, Berrut G, Bouhanick B. The concept of incipient diabetic nephropathy and effect of early antihypertensive intervention. In: Mogensen CE, ed. The kidney and hypertension in diabetes mellitus, 3rd edn. London: Kluwer Academic Publishers, 1996: 351-60.
11. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990; 121: 293-98.
12. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997; 20: 725-34.
13. Pyörälä K. CHD prevention in clinical practice. Lancet 1996; 348 (suppl I): s26-s28.
14. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 117-64.
15. DCCT Study Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial: an economic evaluation. JAMA (in press).
16. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of noninsulin dependent diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 47-68.
17. Moss SE, Klein R, Klein BEF. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81: 1158-62.
18. Geiss LA, Thompson TJ. Are persons with diabetes more likely to die from influenza and pneumonia. Diabetes 1995; 44: 456 (abstr).
19. US Renal Data System. In: USRDS 1994 Annual Data Report. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases, 1994: Appendix D17.
20. Kochanek KD, Hudson BL. Advance report of final mortality statistics, 1992. Monthly Vital Statistics Report 1994; 43: 17.
21. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin dependent diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. Bethesda: NIH, 1995: 233-58.
22. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-68.
23. Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43.
24. Singer DE, Nathan DM, Anderson KM, et al. Association of HbA1 c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-08.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
26. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 28: 103-17.
27. Abraira C, Colwell JA, Nuttall FQ, et al. Cardiovascular events and correlates in the Veterens Affairs Diabetes Feasibility Trial. Arch Intern Med 1997; 157: 181-88.
28. The UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995; 44: 1249-58.
29. Prochaska JO, Prochaska JO, Velicer WF, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994; 13: 39-46.